Literature DB >> 3062268

Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage.

U Dickmann1, E Voth, H Schicha, T Henze, H Prange, D Emrich.   

Abstract

A prospective randomized pilot study of subcutaneous low-dose heparin in the prevention of deep-vein thrombosis and pulmonary embolism was carried out in patients admitted to hospital after intracerebral hemorrhage. A high incidence of deep-vein thrombosis and lung embolism was detected by phleboscintigraphy and lung perfusion scintigraphy, respectively. There was no significant reduction of deep-vein thrombosis and pulmonary embolism in the therapy group. Heparin did not increase the risk of rebleeding.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3062268     DOI： 10.1007/bf01727666

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  8 in total

1.  A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.

Authors:  C Warlow; G Terry; A C Kenmure; A G Beattie; D Ogston; A S Douglas
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

2.  Low-dose heparin after myocardial infarction.

Authors:  A J Handley
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

3.  99mTc red blood cell venography in deep vein thrombosis of the leg: a correlation with contrast venography.

Authors:  R Lisbona; J Stern; V Derbekyan
Journal:  Radiology       Date:  1982-06       Impact factor: 11.105

4.  Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke.

Authors:  S T McCarthy; J J Turner; D Robertson; C J Hawkey; D J Macey
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

5.  Detection of deep venous thrombosis by scanning of 99mtechnetium-labelled red-cell venous pool.

Authors:  W Beswick; R Chmiel; R Booth; I Vellar; E Gilford; C N Chesterman
Journal:  Br Med J       Date:  1979-01-13

6.  Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.

Authors: 
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

7.  Visualizing cardiac blood pool: comparison of three labeling methods.

Authors:  P Neumann; H Schicha; P Schürnbrand; M Bähre; D Emrich
Journal:  Eur J Nucl Med       Date:  1983

8.  [Prevention of venous thrombosis in recent ischaemic cerebrovascular accident: double-blind study with heparin-dihydroergotamine (author's transl)].

Authors:  B Czechanowski; F Heinrich
Journal:  Dtsch Med Wochenschr       Date:  1981-09-25       Impact factor: 0.628
  8 in total
  18 in total

1.  Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Maarten G Lansberg; Martin J O'Donnell; Pooja Khatri; Eddy S Lang; Mai N Nguyen-Huynh; Neil E Schwartz; Frank A Sonnenberg; Sam Schulman; Per Olav Vandvik; Frederick A Spencer; Pablo Alonso-Coello; Gordon H Guyatt; Elie A Akl
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  Early heparin therapy in patients with spontaneous intracerebral haemorrhage.

Authors:  A Boeer; E Voth; T Henze; H W Prange
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

Review 4.  Should anticoagulation be resumed after intracerebral hemorrhage?

Authors:  Joshua N Goldstein; Steven M Greenberg
Journal:  Cleve Clin J Med       Date:  2010-11       Impact factor: 2.321

5.  Risk of thromboembolism following acute intracerebral hemorrhage.

Authors:  Joshua N Goldstein; Louis E Fazen; Lauren Wendell; Yuchiao Chang; Natalia S Rost; Ryan Snider; Kristin Schwab; Rishi Chanderraj; Christopher Kabrhel; Catherine Kinnecom; Emilie Fitzmaurice; Eric E Smith; Steven M Greenberg; Jonathan Rosand
Journal:  Neurocrit Care       Date:  2008-09-23       Impact factor: 3.210

6.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

7.  High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patients.

Authors:  Sophie Samuel; Emitseilu K Iluonakhamhe; Eileen Adair; Natalie Macdonald; Kiwon Lee; Teresa A Allison; Huimahn A Choi
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

8.  Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension.

Authors:  Tzu-Ching Wu; Mallik Kasam; Nusrat Harun; Hen Hallevi; Hesna Bektas; Indrani Acosta; Vivek Misra; Andrew D Barreto; Nicole R Gonzales; George A Lopez; James C Grotta; Sean I Savitz
Journal:  Stroke       Date:  2011-01-21       Impact factor: 7.914

9.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Authors:  Holger J Schünemann; Mary Cushman; Allison E Burnett; Susan R Kahn; Jan Beyer-Westendorf; Frederick A Spencer; Suely M Rezende; Neil A Zakai; Kenneth A Bauer; Francesco Dentali; Jill Lansing; Sara Balduzzi; Andrea Darzi; Gian Paolo Morgano; Ignacio Neumann; Robby Nieuwlaat; Juan J Yepes-Nuñez; Yuan Zhang; Wojtek Wiercioch
Journal:  Blood Adv       Date:  2018-11-27

10.  Impact of practice change in reducing venous thromboembolism in neurocritical overweight patients: 2008-2014.

Authors:  Sophie Samuel; Suhas Bajgur; Jude P Savarraj; Huimahn A Choi
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.